Product ID: SQMIG35C2011
Global Drug Discovery Outsourcing Market Size, Share, Growth Analysis, By Drug Type(Small Molecules, Large molecules), By Workflow(Target Identification & screening, target validation & functional informatics), By Therapeutic area(Respiratory system, oncology), By Application(Hospitals & clinics, medical laboratories) - Industry Forecast 2024-2031
Report ID:
SQMIG35C2011 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|
Tables:
128 |
Figures:
78
Global Drug Discovery Outsourcing Market Regional Insights
North America held the largest global drug discovery outsourcing market in 2021.
The United States dominates North America market. As per the CDC, I.e., the Centers for Disease Control and Prevention, around 1.7 million new cancer cases were reported in 2019 in the US, and about half a million people died of cancer. For every 100,000 individuals in the US, there are 439 new cancer cases and 146 cancer deaths. Furthermore, the large presence of contract research organizations will positively contribute to the growth of the cancer immunotherapy drug discovery outsourcing market.
Europe is also expected to emerge in the global competition due to high capital spending on healthcare infrastructure and streamlining of approval processes. This has led to the safe and quick approval of clinical drugs and treatments in the region, hence contributing to the increasing demand for cancer immunotherapy drugs and treatment options.
Asia Pacific will witness increasing demand for drug discovery outsourcing due to emerging economies such as China and India. The government bodies in these countries have positive reimbursement policies that also provide an impetus to the market in this region.
Global Drug Discovery Outsourcing Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
